AMG 114
Latest Information Update: 10 Sep 2008
At a glance
- Originator Amgen
- Class Antianaemics
- Mechanism of Action Erythropoiesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chemotherapy-induced anaemia
Most Recent Events
- 29 Mar 2004 Preclinical trials in Anaemia in USA (unspecified route)